Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...

Oppenheimer analyst Suraj Kalia maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...

Shares of Abbott Laboratories ABT slumped 0.79% to $116.80 Wednesday, on what proved to be an all-around great trading ...

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...

Abbott Laboratories showcases robust financial performance with a notable increase in net earnings. Strategic acquisitions and product launches strengthen the company's market presence.

So on that note, Abbott Laboratories (NYSE:ABT) looks quite promising in regards to its trends of return on capital. What Is Return On Capital Employed (ROCE)? Just to clarify if you're unsure ...

On Monday, Barclays maintained an Overweight rating on Abbott Labs (NYSE:ABT) shares and increased the price target to $149 from $143. The adjustment follows a favorable verdict for Abbott in a ...

CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that's been weighed down by ongoing litigation for several months. Abbott was cleared Thursday night of ...

Shares of Abbott Laboratories ABT rose 4.61% to $118.60 Friday, on what proved to be an all-around positive trading session ...